Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
MediciNova
MNOV
$64.5M
| $312K | ﹤0.01% |
144,400
+2,100
| +1% | +$4.81K |
|
|
DMRA
3102
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
| $311K | ﹤0.01% |
6,244
+84
| +1% | +$4.43K |
|
3103
Ovid Therapeutics
OVID
$523M
| $311K | ﹤0.01% |
120,600
+800
| +0.7% | +$1.9K |
|
|
CGRN
3104
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $311K | ﹤0.01% |
234,195
+17,354
| +8% | +$30.5K |
|
3105
Pulmatrix
PULM
$5.84M
| $308K | ﹤0.01% |
105,620
+1,500
| +1% | +$5.42K |
|
3106
Kopin
KOPN
$898M
| $307K | ﹤0.01% |
282,064
-237,704
| -46% | -$291K |
|
3107
Praxis Precision Medicines
PRAX
$10.3B
| $307K | ﹤0.01% |
25,333
+1,066
| +4% | +$45K |
|
3108
Establishment Labs
ESTA
$2.25B
| $305K | ﹤0.01% |
4,500
-29,700
| -87% | -$2.04M |
|
3109
Nautilus Biotechnolgy
NAUT
$113M
| $305K | ﹤0.01% |
110,200
+10,700
| +11% | +$22.4K |
|
3110
VTEX
VTEX
$630M
| $305K | ﹤0.01% |
79,500
+17,600
| +28% | +$71.7K |
|
|
RDGT
3111
Ridgetech Inc
RDGT
$3.19M
| $305K | ﹤0.01% |
23
-1
| -4% | -$13.2K |
|
|
ARAV
3112
DELISTED
Aravive, Inc. Common Stock
ARAV
| $305K | ﹤0.01% |
152,713
-24,800
| -14% | -$46.6K |
|
3113
Union Bankshares
UNB
$120M
| $304K | ﹤0.01% |
13,732
-5,600
| -29% | -$139K |
|
|
SAVE
3114
DELISTED
Spirit Airlines, Inc.
SAVE
| $304K | ﹤0.01% |
+17,700
| New | +$331K |
|
|
IMGN
3115
DELISTED
Immunogen Inc
IMGN
| $304K | ﹤0.01% |
+79,140
| New | +$337K |
|
|
SUNW
3116
DELISTED
Sunworks, Inc.
SUNW
| $302K | ﹤0.01% |
209,789
-87,211
| -29% | -$164K |
|
3117
Farmers & Merchants Bancorp
FMAO
$484M
| $301K | ﹤0.01% |
12,381
-11,000
| -47% | -$289K |
|
|
CIZN
3118
DELISTED
Citizens Holding Co.
CIZN
| $301K | ﹤0.01% |
24,935
-1,300
| -5% | -$18.6K |
|
3119
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $300K | ﹤0.01% |
9,500
-60,500
| -86% | -$1.95M |
|
3120
Lisata Therapeutics
LSTA
$10.6M
| $300K | ﹤0.01% |
92,422
+300
| +0.3% | +$1K |
|
3121
ProShares Short S&P500
SH
$839M
| $300K | ﹤0.01% |
+5,000
| New | +$309K |
|
|
WCLD
3122
WisdomTree Cloud Computing Fund
WCLD
$319M
| $300K | ﹤0.01% |
10,100
-1,400
| -12% | -$39.2K |
|
3123
GDS Holdings
GDS
$6.97B
| $299K | ﹤0.01% |
16,000
-300
| -2% | -$6.35K |
|
|
SSY
3124
DELISTED
SunLink Health Systems
SSY
| $298K | ﹤0.01% |
272,578
-1,900
| -0.7% | -$1.86K |
|
|
AFIB
3125
DELISTED
Acutus Medical Inc
AFIB
| $298K | ﹤0.01% |
394,800
+90,300
| +30% | +$118K |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.